Krishna Institute of Medical Sciences (KIMS) Share Price Fall Streak: KIMS slips for second straight session

Krishna Institute of Medical Sciences Share Price Fall Streak is now in its second straight session, with KIMS trading lower at Rs 659.30 as of 22 October 2026 at 9:23:35 AM IST. The cumulative move across the streak stands at -2.82% from the Rs 678.45 starting base, and the latest reading confirms the pattern but does not establish a company-specific cause.

The market value stands at Rs 28,495.34 crore, which keeps Krishna Institute of Medical Sciences in the Large Cap bracket. For a reader, a run of consecutive lower sessions is more informative than a one-off decline because it shows the price has not just softened once; it has stayed under pressure across back-to-back trading sessions. In Univest analysis, that makes the current Krishna Institute of Medical Sciences Share Price Fall Streak worth tracking alongside valuation and peer positioning.

Krishna Institute of Medical Sciences (KIMS) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 659.3
Previous Close	Rs 673.65
Today's Move	-Rs 14.35 (-2.13%)
Open	Rs 674
High	Rs 674
Low	Rs 658.95
Market Capitalisation	Rs 28,495.34 crore

At 22 October 2026 at 9:23:35 AM IST, Krishna Institute of Medical Sciences was trading at Rs 659.30 against the previous close of Rs 673.65, a fall of Rs 14.35 or 2.13%. The day opened at Rs 674 and touched a high of Rs 674 before slipping to a low of Rs 658.95. The latest traded price sat near the lower end of that range, which shows the stock spent most of the session below its opening level. In market-cap terms, the company stood at Rs 28,495.34 crore, which places the move in a Large Cap name rather than a smaller stock where each tick can look more volatile. For Krishna Institute of Medical Sciences Share Price Fall Streak tracking, the key point is that the price kept easing after the prior session’s weakness rather than recovering toward the open. That leaves the Krishna Institute of Medical Sciences Share Price narrative centred on the latest price action and the streak itself, before any broader interpretation comes from fundamentals.

What the Consecutive Declines Show

The second straight session is the main difference between this update and a one-day fall. Krishna Institute of Medical Sciences Share Price Fall Streak now reflects a cumulative decline of -2.82% from Rs 678.45, which is a broader read than the latest -2.13% daily move alone. In Univest framing, the streak matters because it shows the stock has not only traded lower once; it has failed to reverse the prior day’s weakness in the very next session.

That also changes how readers should interpret the current Krishna Institute of Medical Sciences Share Price Fall Streak. The first session established the down move, while the second session confirms that the lower price is being carried forward. The current Krishna Institute of Medical Sciences Share Price Fall Streak therefore gives more weight to the sequence than to a single intraday dip, and it is the sequence that now defines the stock’s near-term tone.

Univest figures confirm the price action, but they do not point to a specific company trigger.

Krishna Institute of Medical Sciences (KIMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 28,495.34 crore
P/E Ratio	138.49x
P/B Ratio	7.48x
ROE	11.04%
ROCE	11.51%
EPS	Rs 4.86
Book Value Per Share	Rs 90.09
Dividend Yield	0%

Krishna Institute of Medical Sciences (KIMS) fundamental metrics show P/E 138.49x, P/B 7.48x, ROE 11.04%, ROCE 11.51%. Taken on their own, these numbers offer context rather than a trading signal.

Krishna Institute of Medical Sciences has a market capitalisation of Rs 28,495.34 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 138.49x, P/B at 7.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.04% and ROCE of 11.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.86, book value per share of Rs 90.09, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.03x, median ROE of 13.07%, median ROCE of 15.83%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	138.49x
Benchmark Median P/E	42.03x
Benchmark Average P/E	92.56x
Benchmark P/E Range	6.48x to 1,528.53x
Company P/B Ratio	7.48x
Benchmark Median P/B	3.67x
Benchmark Average P/B	3.9x
Company ROE	11.04%
Benchmark Median ROE	13.07%
Benchmark Average ROE	10.69%
Company ROCE	11.51%
Benchmark Median ROCE	15.83%
Benchmark Average ROCE	1.93%
Company Market Capitalisation	Rs 28,495.34 crore
Benchmark Median Market Cap	Rs 532.26 crore
Benchmark Average Market Cap	Rs 9,854.74 crore

Krishna Institute of Medical Sciences (KIMS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Krishna Institute of Medical Sciences (KIMS) has a P/E ratio of 138.49x, which is above the benchmark median of 42.03x, a difference of +229.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Krishna Institute of Medical Sciences (KIMS) has a ROE of 11.04%, which is below the benchmark median of 13.07%, a difference of -15.53%. Krishna Institute of Medical Sciences (KIMS) has a ROCE of 11.51%, which is below the benchmark median of 15.83%, a difference of -27.29%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,10,757.32	52.33	11.29	23.54	21.73
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	82,855.61	92.4	4.97	12.95	13.93
Max Healthcare Institute	MAXHEALTH	80,716.62	54.78	7.3	14.53	14.97
Aster DM Healthcare	ASTERDM	58,157.99	177.79	13.4	13.07	16.22
Fortis Healthcare	FORTIS	55,553.6	52.45	5.41	11.32	14.07

Krishna Institute of Medical Sciences (KIMS) has a P/E ratio of 138.49x compared with the displayed peer median of 54.78x. The comparison is relative and should not be read as a recommendation. Its ROE of 11.04% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 11.51% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Krishna Institute of Medical Sciences (KIMS) has a market capitalisation of Rs 28,495.34 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Krishna Institute of Medical Sciences

• The Krishna Institute of Medical Sciences Share Price Fall Streak has stretched to a second straight session, with the cumulative move now at -2.82% from Rs 678.45.
• The latest traded price of Rs 659.30 is below the previous close of Rs 673.65, so the price action remains weak in the near term.
• The company’s P/E of 138.49 and P/B of 7.48 still stand above the same-industry median, even after the decline.
• ROE of 11.04% and ROCE of 11.51% give a separate fundamental read that is below some sector leaders but still positive on an absolute basis.
• The Large Cap market value of Rs 28,495.34 crore keeps the move relevant for readers following sector names with scale.

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company is part of the listed hospital services space, where investors often compare market cap, valuation, return ratios and peer standing rather than only the daily move. For the current Krishna Institute of Medical Sciences Share Price Fall Streak, the key business context is that it sits among large hospital chains and is valued on its earnings and book-value base rather than on income yield, since dividend yield is 0% in the data. That makes the stock sensitive to how the market views its premium pricing relative to sector benchmarks.

Track Krishna Institute of Medical Sciences Share Price on Univest

Use Krishna Institute of Medical Sciences (KIMS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

On Univest, readers can track Krishna Institute of Medical Sciences Share Price movement, valuation ratios, 52-week levels, market capitalisation and broader market insights in one place. The same page also helps monitor KIMS stock analysis, sector comparison and fundamental ratios alongside the latest traded price. For a stock in a second straight decline, that combination helps keep the price action and the fundamentals together.

Frequently Asked Questions

What does the Krishna Institute of Medical Sciences Share Price Fall Streak mean?

Ans. It means the stock has moved lower in two consecutive sessions. The cumulative change across the streak is -2.82% from Rs 678.45, so the pattern is broader than a single-day decline.

How much did Krishna Institute of Medical Sciences fall in the latest session?

Ans. Krishna Institute of Medical Sciences declined by Rs 14.35 in the latest session, or 2.13%. The stock traded between Rs 658.95 and Rs 674, with the latest traded price near the lower end of that range.

What is the market capitalisation of Krishna Institute of Medical Sciences ?

Ans. The company’s market capitalisation stands at Rs 28,495.34 crore. That places it in the Large Cap category and makes the move relevant for readers tracking hospital and healthcare services names.

How is Krishna Institute of Medical Sciences valued now?

Ans. Krishna Institute of Medical Sciences trades at a P/E of 138.49 and a P/B of 7.48. Those levels remain above the same-industry median, so the valuation still carries a premium despite the price fall.

What do ROE and ROCE show for Krishna Institute of Medical Sciences ?

Ans. ROE is 11.04% and ROCE is 11.51%. Both figures help frame how efficiently the business is converting equity and capital employed into returns, even as the share price moves lower.

How does Krishna Institute of Medical Sciences compare with peers?

Ans. The company’s P/E of 138.49 is above Apollo Hospitals, Max Healthcare and Fortis, though below Aster DM Healthcare. Its P/B of 7.48 is also above some peers and below Apollo and Aster.

What is the EPS and book value for Krishna Institute of Medical Sciences ?

Ans. EPS is Rs 4.86 and book value is Rs 90.09 per share. These two figures stay unchanged through the streak and help explain how the current price compares with the earnings and balance-sheet base.

Should investors track Krishna Institute of Medical Sciences on Univest?

Ans. Yes, if they want to follow the latest traded price, valuation ratios, market cap and sector comparison in one place. The KIMS Share Price fall streak makes those metrics more relevant than a standalone daily move.